Insider Selling: Arteris, Inc. (NASDAQ:AIP) CEO Sells 8,432 Shares of Stock

Arteris, Inc. (NASDAQ:AIPGet Free Report) CEO K Charles Janac sold 8,432 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $12.34, for a total value of $104,050.88. Following the sale, the chief executive officer now owns 260,088 shares of the company’s stock, valued at $3,209,485.92. This trade represents a 3.14 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

K Charles Janac also recently made the following trade(s):

  • On Thursday, January 2nd, K Charles Janac sold 6,256 shares of Arteris stock. The stock was sold at an average price of $11.41, for a total value of $71,380.96.
  • On Monday, December 30th, K Charles Janac sold 58,212 shares of Arteris stock. The stock was sold at an average price of $10.33, for a total value of $601,329.96.
  • On Thursday, December 26th, K Charles Janac sold 60,584 shares of Arteris stock. The shares were sold at an average price of $10.42, for a total value of $631,285.28.
  • On Tuesday, December 17th, K Charles Janac sold 14,180 shares of Arteris stock. The stock was sold at an average price of $10.01, for a total value of $141,941.80.
  • On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The shares were sold at an average price of $10.12, for a total value of $180,702.72.
  • On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The shares were sold at an average price of $8.58, for a total value of $10,656.36.

Arteris Price Performance

Shares of AIP opened at $11.25 on Friday. Arteris, Inc. has a 52 week low of $4.83 and a 52 week high of $12.64. The firm has a market cap of $451.99 million, a price-to-earnings ratio of -11.72 and a beta of 1.17. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. The stock has a 50 day moving average of $9.25 and a 200-day moving average of $8.15.

Wall Street Analysts Forecast Growth

Separately, Rosenblatt Securities restated a “buy” rating and set a $15.00 price objective on shares of Arteris in a report on Wednesday, November 6th.

Get Our Latest Stock Analysis on AIP

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. State Street Corp boosted its position in Arteris by 18.5% during the 3rd quarter. State Street Corp now owns 410,578 shares of the company’s stock worth $3,170,000 after acquiring an additional 64,081 shares during the period. Bank of New York Mellon Corp acquired a new stake in shares of Arteris during the second quarter worth $580,000. Dynamic Technology Lab Private Ltd acquired a new position in Arteris during the third quarter valued at $226,000. Geode Capital Management LLC grew its stake in Arteris by 6.6% in the third quarter. Geode Capital Management LLC now owns 597,116 shares of the company’s stock valued at $4,610,000 after purchasing an additional 36,908 shares in the last quarter. Finally, Barclays PLC grew its stake in Arteris by 321.1% in the third quarter. Barclays PLC now owns 39,396 shares of the company’s stock valued at $304,000 after purchasing an additional 30,041 shares in the last quarter. Institutional investors and hedge funds own 64.36% of the company’s stock.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Stories

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.